Overall, women with MS have a 26% increased risk of mental illness during pregnancy and a 33% increased risk after giving birth, compared to women without the degenerative nerve disease.
How the FDA and CMS worked together on a new approach to paying for digital mental health treatments
By establishing coding and separate payment for certain digital mental health devices, this group from CMS and the FDA hopes ...
Pristiq (desvenlafaxine) and Effexor (venlafaxine) are SNRIs. Pristiq treats depression, while Effexor treats depression and ...
In the final stretch of the Biden administration, the Food ... of drug and biological products used during pregnancy, perspectives from interested parties (FDA, academia, industry, health care ...
The U.S. Food and Drug Administration (FDA ... As of Monday, no illnesses had been reported to date in connection with the product, per the FDA. New Age International declined to comment to ...
UNDATED (CNN/CNN Newsource/WKRC) - The FDA just approved a ketamine-derived nasal spray for helping to treat depression. The Food and Drug Administration (FDA) has approved Spravato, a nasal spray ...
The Food and Drug Administration (FDA) approved Johnson & Johnson's ketamine-derived nasal spray to help millions of U.S. patients suffering from severe depression. Spravato, approved as a ...
An ongoing recall of Costco eggs over salmonella has been escalated by the U.S. Food and Drug Administration, who placed the recall ... that use of the product will cause serious, adverse health ...
An ongoing recall of Costco eggs over salmonella has been escalated by the U.S. Food and Drug Administration ... product will cause serious, adverse health consequences or death," according ...
American health watchdog the FDA (U.S. Food and Drug Administration) estimate that up to 10 per ... increased blood pressure ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback